Oncology
1 drug is in development for Lung Adenocarcinoma.
- Companies
- 1
- Clinical trials
- 12
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Lung Adenocarcinoma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| TNG260 | Tango Therapeutics, Inc. (TNGX) |
About this indication
Lung Adenocarcinoma context
Oncology·MeSH: Adenocarcinoma of Lung (D000077192)
Also known as: Adenocarcinoma of Lung, Adenocarcinomas, Lung
Frequently asked questions
How many drugs are in development for Lung Adenocarcinoma?
BioSniper tracks 1 drug in development for Lung Adenocarcinoma across 1 company.
How many clinical trials target Lung Adenocarcinoma?
There are 12 clinical trials targeting Lung Adenocarcinoma tracked by BioSniper.